Latest filing published 12 Jun 2018 for Rein Therapeutics, Inc., €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -83.2%Entry US$104.60 · Close at T+365 US$17.60
- -83.3%Entry US$110.00 · Close at T+365 US$18.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Donald Dougherty: trading record in brief
Donald Dougherty appears in our data through filings on Rein Therapeutics, Inc. shares, published by SEC (Form 4). Between 1 June 2018 and 8 June 2018, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases worth €23k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 12 June 2018 came the latest disclosure, an open-market purchase for €14k in Rein Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Donald Dougherty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$5.4060.5% of flowCommon StockSEC:0000899243-18-016218:0Canonical exit: 6 Sept 2018 (T+90)
- 2,000 shares@ US$5.2439.5% of flowCommon StockSEC:0000899243-18-014929:0Canonical exit: 30 Aug 2018 (T+90)
2 of 2 declarations
